Clinical Trials List
2021-01-04 - 2026-04-30
Phase III
Recruiting3
ICD-10C67.0
Malignant neoplasm of trigone of bladder
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9188.0
Malignant neoplasm of trigone of urinary bladder
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chi-Ping Huang Division of Urology
- Po-Jen Hsiao Division of Urology
- Yi-Huei Chang Division of Urology
- Po-Fan Hsieh Division of Urology
- Hsi-Chin Wu Division of Urology
- Chi-Rei Yang Division of Urology
- 陳冠亨 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- JIAN-HUA HONG Division of Urology
- - - Division of Urology
- YI-KAI CHANG Division of Urology
- Yeong-Shiau Pu Division of Urology
- PO-MING CHOW Division of Urology
- - - Division of Urology
- YU-CHUAN LU Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Chieh Lin Division of Urology
- William Huang Division of Urology
- Tzu-chun Wei Division of Urology
- Yen-Hwa Chang Division of Urology
- Yi-Hsiu Huang Division of Urology
- Tzu-Ping Lin Division of Urology
- Tzu-Hao Huang Division of Urology
- 沈書慧 Division of Radiology
- 陳威任 Division of Urology
- 潘競成 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
115 participants
